Enzymotec (ENZY) Tops Q1 EPS by 7c; Updates FY14 Outlook

Enzymotec (NASDAQ: ENZY) reported Q1 EPS of $0.24, $0.07 better than the analyst estimate of $0.17. Revenue for the quarter came in at $23.7 million versus the consensus estimate of $19.4 million.

Enzymotec sees FY2014 EPS of $0.64 - $0.94, versus the consensus of $0.86. Enzymotec sees FY2014 revenue of $90 - $110 million, versus the consensus of $92.95 million.

For earnings history and earnings-related data on Enzymotec (ENZY) click here.

You May Also Be Interested In

• Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance
• Shotspotter (SSTI) Misses Q2 EPS by 19c; Offers Guidance
• York Space Systems, Inc. (YSS) Reports Q2 Loss of $0.31 ; Offers Guidance